A significant number of security control weaknesses are jeopardizing the confidentiality, integrity and availability of the Food and Drug Administration’s information and systems, putting industry and public health data at risk, according to an audit by the Government Accountability Office.

“The agency did not fully or consistently implement access controls, which are intended to prevent, limit and detect unauthorized access to computing resources,” the GAO’s report says. “Specifically, FDA did not always adequately protect the boundaries of its network, consistently identify and authenticate system users, limit users’ access to only what was required to perform their duties, encrypt sensitive data, consistently audit and monitor system activity, and conduct physical security reviews of its facilities.”

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access